Phathom Pharmaceuticals, Inc. (PHAT) NASDAQ

8.71

+0.09(+1.04%)

Updated at July 30 04:00PM

Currency In USD

Valuation

Market Cap512.99M
Enterprise Value417.64M
P/E Ratio-2.49
PEG Ratio-1.21
Price/Sales Ratio7.43
Price/Book Ratio-1.85
Enterprise/Revenue7.32
Enterprise/EBITDA-2.18

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin-3.07
Operating Margin-3.5

Management Effectiveness

Return On Assets-0.85
Return On Equity0.99

Income Statement

Revenue55.25M
Revenue/Share1.14
Gross Profit47.28M
EBITDA-261.52M
Net Income-334.33M
Diluted EPS-5.29

Balance Sheet

Total Cash212.32M
Total Cash/Share2.95
Total Debt203.56M
Total Debt/Equity-0.6
Current Ratio3.58
Book Value Per Share-4.7

Price History

52-Week Change-26.31
52-Week High19.71
52-Week Low2.21
Moving Average 50 Days7.94
Moving Average 200 Days7.83

Statistics

Average Volume2.75M
Shares Outstanding69.81M
% Held by Institutions87.82

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A